Abstract

Immunotherapy has emerged as a revolutionary approach in cancer treatment, harnessing the body's immune system to target and destroy cancer cells. Over the past decades, significant advancements have been made in understanding the complexities of the immune response against cancer and developing novel immunotherapeutic strategies. This review discusses the current landscape of immunotherapy, including immune checkpoint inhibitors, adoptive cell therapies, and therapeutic vaccines. Additionally, it explores ongoing challenges and future directions in optimizing immunotherapy efficacy and broadening its applicability across various cancer types.